Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (568)	4/1/1999 8:56:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 4974

Patrick Gage in an earlier MLNM release, and now Steven C. Clark, Senior Vice President, Discovery Research, Wyeth-Ayerst Research??? This is great! AHP is obviously the most successful pharma at integrating "biotech performers" into their organization. If BMS had been as successful at picking those who it attempted to integrate, they'd be a heck of a lot better off. Nice release, PB. Thanks for bringing it to our attention! You don't suppose that the Bayer target could be MEDI??